111 related articles for article (PubMed ID: 15808910)
1. Substance P and the neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis.
Jönsson M; Norrgård O; Forsgren S
Peptides; 2005 May; 26(5):799-814. PubMed ID: 15808910
[TBL] [Abstract][Full Text] [Related]
2. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical demonstration of the NK(1) tachykinin receptor on muscle and epithelia in guinea pig intestine.
Southwell BR; Furness JB
Gastroenterology; 2001 Apr; 120(5):1140-51. PubMed ID: 11266378
[TBL] [Abstract][Full Text] [Related]
4. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease.
Liu L; Shang F; Markus I; Burcher E
J Pharmacol Exp Ther; 2002 Aug; 302(2):627-35. PubMed ID: 12130725
[TBL] [Abstract][Full Text] [Related]
5. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
6. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
7. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.
Goode T; O'Connell J; Anton P; Wong H; Reeve J; O'Sullivan GC; Collins JK; Shanahan F
Gut; 2000 Sep; 47(3):387-96. PubMed ID: 10940277
[TBL] [Abstract][Full Text] [Related]
8. Decrease in binding for the neuropeptide VIP in response to marked inflammation of the mucosa in ulcerative colitis.
Jönsson M; Norrgård O; Hansson M; Forsgren S
Ann N Y Acad Sci; 2007 Jun; 1107():280-9. PubMed ID: 17804556
[TBL] [Abstract][Full Text] [Related]
9. Substance P receptor expression in patients with inflammatory bowel disease. Determination by three different techniques, i.e., storage phosphor autoradiography, RT-PCR and immunohistochemistry.
ter Beek WP; Biemond I; Muller ES; van den Berg M; Lamers CB
Neuropeptides; 2007 Oct; 41(5):301-6. PubMed ID: 17602742
[TBL] [Abstract][Full Text] [Related]
10. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine.
Renzi D; Pellegrini B; Tonelli F; Surrenti C; Calabrò A
Am J Pathol; 2000 Nov; 157(5):1511-22. PubMed ID: 11073811
[TBL] [Abstract][Full Text] [Related]
11. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
Yantiss RK; Das KM; Farraye FA; Odze RD
Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
[TBL] [Abstract][Full Text] [Related]
13. Presence of substance P and the neurokinin-1 receptor in tenocytes of the human Achilles tendon.
Andersson G; Danielson P; Alfredson H; Forsgren S
Regul Pept; 2008 Oct; 150(1-3):81-7. PubMed ID: 18394729
[TBL] [Abstract][Full Text] [Related]
14. Rapid changes in substance P signaling and neutral endopeptidase induced by skin-scratching stimulation in mice.
Yamaoka J; Kawana S
J Dermatol Sci; 2007 Nov; 48(2):123-32. PubMed ID: 17692507
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin NK2 receptor and functional mechanisms in human colon: changes with indomethacin and in diverticular disease and ulcerative colitis.
Burcher E; Shang F; Warner FJ; Du Q; Lubowski DZ; King DW; Liu L
J Pharmacol Exp Ther; 2008 Jan; 324(1):170-8. PubMed ID: 17959748
[TBL] [Abstract][Full Text] [Related]
16. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
Gillespie E; Leeman SE; Watts LA; Coukos JA; O'Brien MJ; Cerda SR; Farraye FA; Stucchi AF; Becker JM
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17420-5. PubMed ID: 21969570
[TBL] [Abstract][Full Text] [Related]
17. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus.
González Moles MA; Esteban F; Ruiz-Avila I; Gil Montoya JA; Brener S; Bascones-Martínez A; Muñoz M
Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
19. Substance P-mediated expression of the pro-angiogenic factor CCN1 modulates the course of colitis.
Koon HW; Zhao D; Xu H; Bowe C; Moss A; Moyer MP; Pothoulakis C
Am J Pathol; 2008 Aug; 173(2):400-10. PubMed ID: 18599605
[TBL] [Abstract][Full Text] [Related]
20. Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: report of two cases.
Uzunismail H; Hatemi I; Doğusoy G; Akin O
Turk J Gastroenterol; 2006 Mar; 17(1):53-7. PubMed ID: 16830279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
